Prestige Consumer Healthcare Inc. (PBH)
NYSE: PBH · Real-Time Price · USD
78.72
+0.06 (0.08%)
Dec 20, 2024, 4:00 PM EST - Market closed
PBH Income Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
Operating Revenue | 1,110 | 1,125 | 1,128 | 1,087 | 943.32 | 962.94 | Upgrade
|
Other Revenue | 0.84 | 0.31 | 0.11 | 0.04 | 0.04 | 0.07 | Upgrade
|
Revenue | 1,111 | 1,125 | 1,128 | 1,087 | 943.37 | 963.01 | Upgrade
|
Revenue Growth (YoY) | -1.45% | -0.21% | 3.76% | 15.21% | -2.04% | -1.31% | Upgrade
|
Cost of Revenue | 488.55 | 492.79 | 494.88 | 458.94 | 389.67 | 406.55 | Upgrade
|
Gross Profit | 622.11 | 632.57 | 632.84 | 627.87 | 553.7 | 556.46 | Upgrade
|
Selling, General & Admin | 265.2 | 259.47 | 252.42 | 259.7 | 223.7 | 236.31 | Upgrade
|
Operating Expenses | 296.74 | 290.14 | 285.04 | 291.79 | 253.86 | 265.3 | Upgrade
|
Operating Income | 325.37 | 342.43 | 347.8 | 336.08 | 299.84 | 291.16 | Upgrade
|
Interest Expense | -57.25 | -67.16 | -69.16 | -64.29 | -82.33 | -96.22 | Upgrade
|
Other Non Operating Income (Expenses) | -1.14 | 0.76 | -2.34 | -1.05 | 1.37 | -1.63 | Upgrade
|
EBT Excluding Unusual Items | 266.97 | 276.03 | 276.3 | 270.74 | 218.87 | 193.31 | Upgrade
|
Merger & Restructuring Charges | - | - | - | -5.1 | - | - | Upgrade
|
Impairment of Goodwill | - | - | -48.81 | -0.3 | -1.25 | - | Upgrade
|
Asset Writedown | - | - | -321.41 | -0.76 | -1.19 | - | Upgrade
|
Other Unusual Items | - | - | - | -2.12 | -12.33 | -2.16 | Upgrade
|
Pretax Income | 266.97 | 276.03 | -93.92 | 262.46 | 204.11 | 191.15 | Upgrade
|
Income Tax Expense | 61.02 | 66.69 | -11.61 | 57.08 | 39.43 | 48.87 | Upgrade
|
Net Income | 205.95 | 209.34 | -82.31 | 205.38 | 164.68 | 142.28 | Upgrade
|
Net Income to Common | 205.95 | 209.34 | -82.31 | 205.38 | 164.68 | 142.28 | Upgrade
|
Net Income Growth | - | - | - | 24.71% | 15.74% | - | Upgrade
|
Shares Outstanding (Basic) | 50 | 50 | 50 | 50 | 50 | 51 | Upgrade
|
Shares Outstanding (Diluted) | 50 | 50 | 50 | 51 | 51 | 51 | Upgrade
|
Shares Change (YoY) | 0.88% | 0.58% | -1.87% | 0.47% | -1.05% | -1.78% | Upgrade
|
EPS (Basic) | 4.14 | 4.21 | -1.65 | 4.09 | 3.28 | 2.81 | Upgrade
|
EPS (Diluted) | 4.10 | 4.17 | -1.65 | 4.04 | 3.25 | 2.78 | Upgrade
|
EPS Growth | - | - | - | 24.31% | 16.91% | - | Upgrade
|
Free Cash Flow | 254.64 | 239.38 | 221.93 | 250.28 | 213.36 | 202.56 | Upgrade
|
Free Cash Flow Per Share | 5.07 | 4.77 | 4.45 | 4.92 | 4.22 | 3.96 | Upgrade
|
Gross Margin | 56.01% | 56.21% | 56.12% | 57.77% | 58.69% | 57.78% | Upgrade
|
Operating Margin | 29.30% | 30.43% | 30.84% | 30.92% | 31.78% | 30.23% | Upgrade
|
Profit Margin | 18.54% | 18.60% | -7.30% | 18.90% | 17.46% | 14.77% | Upgrade
|
Free Cash Flow Margin | 22.93% | 21.27% | 19.68% | 23.03% | 22.62% | 21.03% | Upgrade
|
EBITDA | 356.91 | 373.1 | 380.43 | 368.17 | 330 | 320.15 | Upgrade
|
EBITDA Margin | 32.14% | 33.15% | 33.73% | 33.88% | 34.98% | 33.24% | Upgrade
|
D&A For EBITDA | 31.54 | 30.68 | 32.63 | 32.09 | 30.16 | 29 | Upgrade
|
EBIT | 325.37 | 342.43 | 347.8 | 336.08 | 299.84 | 291.16 | Upgrade
|
EBIT Margin | 29.30% | 30.43% | 30.84% | 30.92% | 31.78% | 30.23% | Upgrade
|
Effective Tax Rate | 22.86% | 24.16% | - | 21.75% | 19.32% | 25.57% | Upgrade
|
Revenue as Reported | 1,111 | 1,125 | 1,128 | 1,087 | 943.37 | 963.01 | Upgrade
|
Advertising Expenses | - | 153.32 | 145.06 | 157.34 | 140.59 | 147.19 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.